Work

The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease

Year: 2006

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2006.03.064

Authors: Marina S. Boukhvalova, Gregory A. Prince, Layla Soroush, Dolores C. Harrigan, Stefanie N. Vogel, Jorge C.G. Blanco

Institution: University of Maryland, Baltimore

Language: English

Topic: Respiratory viral infections research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases

Awards: EARLY ENDOTOXIN TOLERANCE: CELLULAR/MOLECULAR MECHANISMS, The role of TLR4 and RSV F protein in immunity to RSV

OpenAlex ID: W1973200628

FWCI: 2.962

Cites: 54

Cited by: 106

Related to: 10